ArticleClinical cancer research : an official journal of the American Association for Cancer Research2026

Preexisting TCR Clones Drive Major Pathologic Responses in Patients with HNSCC Treated with Dual Immune Checkpoint Inhibitors.

Huaibin Ge et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.